Clinical Trials Browser

Completed × Neoplasm, Residual × Imatinib Mesylate × Clear all

NCT00267085 2012-08-07

Synthetic Vaccine in Patients With Chronic Myeloid Leukemia and Minimal Residual Disease

Phase 2 Completed

11 enrolled 6 charts

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Neoplasm, Residual